Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
3.
Semin Arthritis Rheum ; 46(3): 286-290, 2016 12.
Article in English | MEDLINE | ID: mdl-27373499

ABSTRACT

OBJECTIVE: The association between psoriatic arthritis (PsA) disease activity and lipid profiles has not been explored. We studied the association between active peripheral arthritis and/or enthesitis/daclylitis with lipid measurements in PsA. METHODS: We conducted a cross-sectional study of PsA patients enrolled in the Consortium of Rheumatology Researchers of North American (CORRONA) registry. Low activity was defined as Clinical Disease Activity Index (CDAI) ≤ 10 without enthesitis or dactylitis. Moderate-to-high peripheral disease activity was defined as CDAI > 10 and/or the presence of enthesitis/dactylitis. RESULTS: Of the 4672 patients with PsA enrolled in the CORRONA registry from June 2008 to October 2012, 725 (15.5%) had complete data on CDAI and lipid measurements. Of them, 284 (39%) patients had CDAI > 10 and/or enthesitis/dactylitis. Moderate-to-high group included more women and more current smokers. Patients with moderate-to-high disease activity had shorter duration of disease, and were more likely to be on prednisone, but less likely to use tumor necrosis factor (TNF) inhibitors. Moderate-to-high peripheral disease activity was associated with abnormal total cholesterol (TC) (>200mg/dl), odds ratio (OR) = 1.58; 95% CI: (1.11, 2.24); p = 0.01, and abnormal triglycerides (TG) (>150mg/dl), OR = 1.64; 95% CI: (1.16, 2.32); p = 0.005, after adjusting for gender, duration of PsA, smoking, body mass index, diabetes, modified Heath Assessment Questionnaire scores, as well as the following medications: methotrexate, other non-biologic disease modifying anti-rheumatic drugs, prednisone, TNF inhibitors, cholesterol lowering medications, and fish oil. The presence of enthesitis and/or dactylitis, irrespective of CDAI scores, was associated with abnormal TC, OR = 1.64; 95% CI: (1.08, 2.48); p = 0.02. CONCLUSION: Our findings suggest an association between peripheral joint inflammation and lipid dysregulation in PsA. Further studies are needed to determine if treating PsA improves lipid profiles and cardiovascular mortality.


Subject(s)
Arthritis, Psoriatic/blood , Atherosclerosis/blood , Cholesterol, HDL/blood , Cholesterol, LDL/blood , Hyperlipidemias/blood , Registries , Triglycerides/blood , Adult , Aged , Anticholesteremic Agents/therapeutic use , Antirheumatic Agents/therapeutic use , Arthritis, Psoriatic/complications , Arthritis, Psoriatic/drug therapy , Arthritis, Psoriatic/immunology , Atherosclerosis/etiology , Cholesterol/blood , Cohort Studies , Cross-Sectional Studies , Female , Humans , Hyperlipidemias/complications , Hyperlipidemias/drug therapy , Inflammation , Logistic Models , Male , Middle Aged , Odds Ratio , Prospective Studies
4.
Arthritis Care Res (Hoboken) ; 66(4): 600-7, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24115739

ABSTRACT

OBJECTIVE: We compared the prevalence and the clustering of the metabolic syndrome (MetS) components (obese body mass index [BMI; ≥30 kg/m(2) ], hypertriglyceridemia, low high-density lipids, hypertension, and diabetes mellitus) in patients with psoriatic arthritis (PsA) and rheumatoid arthritis (RA) in the Consortium of Rheumatology Researchers of North America (CORRONA) Registry. METHODS: We included CORRONA participants with a rheumatologist-confirmed clinical diagnosis of PsA or RA with complete data. We used a modified definition of MetS that did not include insulin resistance, waist circumference, or blood pressure measurements. Logistic regression models were adjusted for age, sex, and race. RESULTS: In the overall CORRONA population, the rates of diabetes mellitus and obesity were significantly higher in PsA compared with RA. In 294 PsA and 1,162 RA participants who had lipids measured, the overall prevalence of MetS in PsA versus RA was 27% versus 19%. The odds ratio (OR) of MetS in PsA versus RA was 1.44 (95% confidence interval [95% CI] 1.05-1.96, P = 0.02). The prevalence of hypertriglyceridemia was higher in PsA compared with RA (38% versus 28%; OR 1.51 [95% CI 1.15-1.98], P = 0.003). The prevalence of type 2 diabetes mellitus was also higher in PsA compared with RA (15% versus 11%; OR 1.56 [95% CI 1.07-2.28], P = 0.02) in the adjusted model. Similarly, higher rates of hypertriglyceridemia and diabetes mellitus were observed in the subgroup of PsA and RA patients with obese BMI. CONCLUSION: Compared with RA, PsA is associated with higher rates of obesity, diabetes mellitus, and hypertriglyceridemia.


Subject(s)
Arthritis, Psoriatic/epidemiology , Arthritis, Rheumatoid/epidemiology , Metabolic Syndrome/epidemiology , Registries , Adult , Aged , Arthritis, Psoriatic/blood , Arthritis, Psoriatic/complications , Arthritis, Rheumatoid/blood , Arthritis, Rheumatoid/complications , Cross-Sectional Studies , Diabetes Complications/epidemiology , Female , Humans , Lipids/blood , Male , Metabolic Syndrome/complications , Middle Aged , Obesity/complications , Obesity/epidemiology , Prevalence , United States/epidemiology
5.
Clin Rheumatol ; 30(10): 1385-92, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21706168

ABSTRACT

In order to describe the clinical and serologic features of a cutaneous vasculitis due to cocaine contaminated with the adulterant levamisole, we report four new cases of this syndrome along with 12 previously reported cases identified through a PubMed Literature search (1964 to March 2011). Of the 16 patients described, the average age was 43, with a female predominance (81% of patients). Over half of patients had involvement of the earlobes, and the rash frequently affected the extremities in a "retiform" pattern. Leukopenia or neutropenia was reported in 56% of patients. Ninety-three percent were anti-neutrophil cytoplasmic antibody positive, and 63% tested positive for anti-phospholipid antibodies. The predominant pattern seen on histopathological examination of the skin was small vessel vasculitis and/or a thrombotic vasculopathy. Treatment in these patients varied widely, with several patients showing improvement or resolution of the rash without specific therapy following cessation of illicit drug use. This new cutaneous vasculitis syndrome can be recognized by its characteristic rash and skin pathology, together with leukopenia and autoantibody production. Certain clinical features can be attributed to the adulterant levamisole, though cocaine as well may play a role in its pathogenesis.


Subject(s)
Adjuvants, Immunologic/adverse effects , Cocaine/adverse effects , Drug Contamination , Levamisole/toxicity , Skin Diseases, Vascular/chemically induced , Systemic Vasculitis/chemically induced , Adjuvants, Immunologic/analysis , Adult , Antibodies, Antineutrophil Cytoplasmic/blood , Cocaine/chemistry , Cocaine-Related Disorders , Female , Humans , Levamisole/analysis , Male , Middle Aged , Skin/blood supply , Skin/pathology , Skin Diseases, Vascular/pathology , Systemic Vasculitis/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...